small molecule

CEPHALEXIN

CEPHALEXIN

Loss of exclusivityloss of exclusivity
CompanyJEROME STEVENS PHARMACEUTICALS INC

Drug detail

Brand nameCEPHALEXIN
Active ingredientCEPHALEXIN
StrengthEQ 250MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 1988
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CEPHALEXIN patent cliff — loss of exclusivity — | CliffBio